High-density lipoproteins, inflammation and oxidative stress

被引:133
作者
Tabet, Fatiha [1 ]
Rye, Kerry-Anne [1 ,2 ,3 ]
机构
[1] Heart Res Inst, Lipid Res Grp, Camperdown, NSW 2050, Australia
[2] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia
[3] Univ Melbourne, Dept Med, Melbourne, Vic 3065, Australia
基金
英国医学研究理事会;
关键词
antioxidant; cholesterol; coronary heart disease; high-density lipoprotein (HDL); inflammation; APOLIPOPROTEIN-A-I; PHOSPHOLIPID TRANSFER PROTEIN; ADHESION MOLECULE EXPRESSION; REVERSE CHOLESTEROL TRANSPORT; CORONARY-ARTERY-DISEASE; ESTER TRANSFER PROTEIN; LIPOPOLYSACCHARIDE-BINDING PROTEIN; RANDOMIZED CONTROLLED-TRIAL; SUPEROXIDE ANION PRODUCTION; E-DEFICIENT MICE;
D O I
10.1042/CS20080106
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Plasma levels of HDL (high-density lipoprotein)-cholesterol are strongly and inversely correlated with atherosclerotic cardiovascular disease. Both clinical and epidemiological studies have reported an inverse and independent association between serum HDL-cholesterol levels and CHD (coronary heart disease) risk. The cardioprotective effects of HDLs have been attributed to several mechanisms, including their involvement in the reverse cholesterol transport pathway. HDLs also have antioxidant, anti-inflammatory and antithrombotic properties and promote endothelial repair, all of which are likely to contribute to their ability to prevent CHD. The first part of this review summarizes what is known about the origins and metabolism of HDL. We then focus on the anti-inflammatory and antioxidant properties of HDL and discuss why these characteristics are cardioprotective.
引用
收藏
页码:87 / 98
页数:12
相关论文
共 50 条
  • [41] High-density lipoproteins and immune response: A review
    Grao-Cruces, Elena
    Lopez-Enriquez, Soledad
    Martin, Maria E.
    Montserrat-de la Paz, Sergio
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 195 : 117 - 123
  • [42] Treatment options for low high-density lipoproteins
    Hafiane, Anouar
    Kellett, Samantha
    Genest, Jacques
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2014, 21 (02) : 134 - 139
  • [43] High-Density Lipoproteins and Serum Amyloid A (SAA)
    Webb, Nancy R.
    CURRENT ATHEROSCLEROSIS REPORTS, 2021, 23 (02)
  • [44] Recombinant High-Density Lipoprotein Formulations
    Vucic, Esad
    Rosenson, Robert S.
    CURRENT ATHEROSCLEROSIS REPORTS, 2011, 13 (01) : 81 - 87
  • [45] Intrinsic enzymes of high-density lipoprotein
    Le, Ngoc-Anh
    Walter, Mary F.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2007, 1 (01) : 20 - 30
  • [46] Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease
    Estrada-Luna, Diego
    Araceli Ortiz-Rodriguez, Maria
    Medina-Briseno, Lizett
    Carreon-Torres, Elizabeth
    Alejandra Izquierdo-Vega, Jeannett
    Sharma, Ashutosh
    Carlos Cancino-Diaz, Juan
    Perez-Mendez, Oscar
    Belefant-Miller, Helen
    Betanzos-Cabrera, Gabriel
    MOLECULES, 2018, 23 (11):
  • [47] Dusty Punch Cards and an Eternal Enigma: High-Density Lipoproteins and Atherosclerosis
    Kleber, Marcus E.
    Grammer, Tanja B.
    Kassner, Ursula
    Silbernagel, Guenther
    Maerz, Winfried
    DRUGS, 2014, 74 (05) : 513 - 520
  • [48] High-density lipoprotein subfractions: current views and clinical practice applications
    Martin, Seth S.
    Jones, Steven R.
    Toth, Peter P.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2014, 25 (07) : 329 - 336
  • [49] High-density lipoproteins: A promising tool against cancer
    Ossoli, Alice
    Wolska, Anna
    Remaley, Alan T.
    Gomaraschi, Monica
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2022, 1867 (01):
  • [50] Recombinant high-density lipoproteins and their use in cardiovascular diseases
    Cao, Yi-ni
    Xu, Lu
    Han, Ying-chun
    Wang, Yu-nan
    Liu, George
    Qi, Rong
    DRUG DISCOVERY TODAY, 2017, 22 (01) : 180 - 185